The plasma membrane redox system in Alzheimer's disease

Experimental Neurology

Volumn 228, Issue 1, 2011, Pages 9-14

  Adlard, P A ^a   Bush, A I ^a  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 8 HYDROXYGUANOSINE; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; CYTOCHROME B5 REDUCTASE; CYTOSINE; DNA; GUANOSINE DERIVATIVE; MEVALONIC ACID; PRESENILIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RNA; TAU PROTEIN; THYMINE; UBIDECARENONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ANTIOXIDANT ACTIVITY; CELL MEMBRANE; CELL PROTECTION; DIET SUPPLEMENTATION; DISEASE MODEL; ELECTRON TRANSPORT; ENZYME ACTIVITY; GENE MUTATION; HUMAN; LIPID PEROXIDATION; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NONHUMAN; NOTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL;

ALZHEIMER DISEASE; ANIMALS; CELL MEMBRANE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 79851514005     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.12.009     Document Type: Note

References (112)

1. Abdul H.M., Sultana R., St Clair D.K., Markesbery W.R., Butterfield D.A. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age. Free Radic. Biol. Med. 2008, 45:1420-1425.
2. Abe T., Tohgi H., Isobe C., Murata T., Sato C. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease. J. Neurosci. Res. 2002, 70:447-450.
3. Adlard P.A., Bush A.I. Metals and Alzheimer's disease. J. Alzheimers Dis. 2006, 10:145-163.
4. Adlard P.A., Cherny R.A., Finkelstein D.I., Gautier E., Robb E., Cortes M., Volitakis I., Liu X., Smith J.P., Perez K., Laughton K., Li Q.X., Charman S.A., Nicolazzo J.A., Wilkins S., Deleva K., Lynch T., Kok G., Ritchie C.W., Tanzi R.E., Cappai R., Masters C.L., Barnham K.J., Bush A.I. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 2008, 59:43-55.
5. Apelt J., Bigl M., Wunderlich P., Schliebs R. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. Int. J. Dev. Neurosci. 2004, 22:475-484.
6. Battino M., Bompadre S., Leone L., Devecchi E., Degiuli A., D'Agostino F., Cambie G., D'Agostino M., Faggi L., Colturani G., Gorini A., Villa R.F. Coenzyme Q, Vitamin E and Apo-E alleles in Alzheimer Disease. Biofactors 2003, 18:277-281.
7. Battino M., Ferri E., Gorini A., Federico Villa R., Rodriguez Huertas J.F., Fiorella P., Genova M.L., Lenaz G., Marchetti M. Natural distribution and occurrence of coenzyme Q homologues. Membr. Biochem. 1990, 9:179-190.
8. Behl C., Davis J., Cole G.M., Schubert D. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem. Biophys. Res. Commun. 1992, 186:944-950.
9. Beyer R.E., Segura-Aguilar J., di Bernardo S., Cavazzoni M., Fato R., Fiorentini D., Galli M.C., Setti M., Landi L., Lenaz G. The two-electron quinone reductase DT-diaphorase generates and maintains the antioxidant (reduced) form of coenzyme Q in membranes. Mol. Aspects Med. 1997, 18(Suppl):S15-S23.
10. Bian J.T., Zhao H.L., Zhang Z.X., Bi X.H., Zhang J.W. Association of NAD(P)H:quinone oxidoreductase 1 polymorphism and Alzheimer's disease in Chinese. J. Mol. Neurosci. 2008, 34:235-240.
11. Boothby L.A., Doering P.L. Vitamin C and vitamin E for Alzheimer's disease. Ann. Pharmacother. 2005, 39:2073-2080.
12. Bourdel-Marchasson I., Delmas-Beauvieux M.C., Peuchant E., Richard-Harston S., Decamps A., Reignier B., Emeriau J.P., Rainfray M. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing 2001, 30:235-241.
13. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Meth. Enzymol. 1984, 105:429-435.
14. Brunmark A., Cadenas E., Lind C., Segura-Aguilar J., Ernster L. DT-diaphorase-catalyzed two-electron reduction of quinone epoxides. Free Radic. Biol. Med. 1987, 3:181-188.
15. Burton G.W., Joyce A., Ingold K.U. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?. Arch. Biochem. Biophys. 1983, 221:281-290.
16. Butterfield D.A., Castegna A., Drake J., Scapagnini G., Calabrese V. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr. Neurosci. 2002, 5:229-239.
17. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem. Pharmacol. 1995, 49:127-140.
18. de Bustos F., Molina J.A., Jimenez-Jimenez F.J., Garcia-Redondo A., Gomez-Escalonilla C., Porta-Etessam J., Berbel A., Zurdo M., Barcenilla B., Parrilla G., Enriquez-de-Salamanca R., Arenas J. Serum levels of coenzyme Q10 in patients with Alzheimer's disease. J. Neural Transm. 2000, 107:233-239.
19. Duce J.A., Bush A.I. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics. Prog. Neurobiol. 2010, 92:1-18.
20. Duffy S., So A., Murphy T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 1998, 71:69-77.
21. Edlund C., Soderberg M., Kristensson K., Dallner G. Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's disease. Biochem. Cell Biol. 1992, 70:422-428.
22. Engelhart M.J., Geerlings M.I., Ruitenberg A., van Swieten J.C., Hofman A., Witteman J.C., Breteler M.M. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002, 287:3223-3229.
23. Ernster L. DT-diaphorase. Meth. Enzymol. 1967, 10:309-317.
24. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1995, 1271:195-204.
25. Ernster L., Navazio F. Soluble diaphorase in animal tissues. Acta Chem. Scand. 1958, 12:595-602.
26. Ferrante R.J., Andreassen O.A., Dedeoglu A., Ferrante K.L., Jenkins B.G., Hersch S.M., Beal M.F. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease. J. Neurosci. 2002, 22:1592-1599.
27. Forsmark-Andree P., Dallner G., Ernster L. Endogenous ubiquinol prevents protein modification accompanying lipid peroxidation in beef heart submitochondrial particles. Free Radic. Biol. Med. 1995, 19:749-757.
28. Gabbita S.P., Lovell M.A., Markesbery W.R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. 1998, 71:2034-2040.
29. Garcia-Alloza M., Dodwell S.A., Meyer-Luehmann M., Hyman B.T., Bacskai B.J. Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model. J. Neuropathol. Exp. Neurol. 2006, 65:1082-1089.
30. Glaso M., Nordbo G., Diep L., Bohmer T. Reduced concentrations of several vitamins in normal weight patients with late-onset dementia of the Alzheimer type without vascular disease. J. Nutr. Health Aging 2004, 8:407-413.
31. Halliwell B., Gutteridge J.M. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 1984, 219:1-14.
32. Huang X., Atwood C.S., Hartshorn M.A., Multhaup G., Goldstein L.E., Scarpa R.C., Cuajungco M.P., Gray D.N., Lim J., Moir R.D., Tanzi R.E., Bush A.I. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999, 38:7609-7616.
33. Hung Y.H., Bush A.I., Cherny R.A. Copper in the brain and Alzheimer's disease. J. Biol. Inorg. Chem. 2010, 15:61-76.
34. Hyun D.H., Mughal M.R., Yang H., Lee J.H., Ko E.J., Hunt N.D., de Cabo R., Mattson M.P. The plasma membrane redox system is impaired by amyloid beta-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice. Exp. Neurol. 2010, 225:423-429.
35. Ingold K.U., Webb A.C., Witter D., Burton G.W., Metcalfe T.A., Muller D.P. Vitamin E remains the major lipid-soluble, chain-breaking antioxidant in human plasma even in individuals suffering severe vitamin E deficiency. Arch. Biochem. Biophys. 1987, 259:224-225.
36. Isaac M.G., Quinn R., Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst. Rev. 2008, 3:1-25.
37. Isobe C., Abe T., Terayama Y. Increase in the oxidized/total coenzyme Q-10 ratio in the cerebrospinal fluid of Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 2009, 28:449-454.
38. Jeandel C., Nicolas M.B., Dubois F., Nabet-Belleville F., Penin F., Cuny G. Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 1989, 35:275-282.
39. Jimenez-Jimenez F.J., de Bustos F., Molina J.A., Benito-Leon J., Tallon-Barranco A., Gasalla T., Orti-Pareja M., Guillamon F., Rubio J.C., Arenas J., Enriquez-de-Salamanca R. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease. J. Neural Transm. 1997, 104:703-710.
40. Kagan V.E., Tyurina Y.Y., Witt E. Role of coenzyme Q and superoxide in vitamin E cycling. Subcell. Biochem. 1998, 30:491-507.
41. Koppal T., Subramaniam R., Drake J., Prasad M.R., Dhillon H., Butterfield D.A. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition. Brain Res. 1998, 786:270-273.
42. Landi L., Fiorentini D., Galli M.C., Segura-Aguilar J., Beyer R.E. DT-Diaphorase maintains the reduced state of ubiquinones in lipid vesicles thereby promoting their antioxidant function. Free Radic. Biol. Med. 1997, 22:329-335.
43. Lass A., Forster M.J., Sohal R.S. Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radic. Biol. Med. 1999, 26:1375-1382.
44. Lass A., Kwong L., Sohal R.S. Mitochondrial coenzyme Q content and aging. Biofactors 1999, 9:199-205.
45. Lass A., Sohal R.S. Electron transport-linked ubiquinone-dependent recycling of alpha-tocopherol inhibits autooxidation of mitochondrial membranes. Arch. Biochem. Biophys. 1998, 352:229-236.
46. Li G., Jack C.R., Yang X.F., Yang E.S. Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: an in vivo volume MRI study. Biofactors 2008, 32:169-178.
47. Lind C., Vadi H., Ernster L. Metabolism of benzo(a)pyrene-3, 6-quinone and 3-hydroxybenzo(a)pyrene in liver microsomes from 3-methylcholanthrene-treated rats. A possible role of DT-diaphorase in the formation of glucuronyl conjugates. Arch. Biochem. Biophys. 1978, 190:97-108.
48. Littarru G.P., Tiano L. Clinical aspects of coenzyme Q10: an update. Nutrition 2010, 26:250-254.
49. Lloret A., Badia M.C., Mora N.J., Pallardo F.V., Alonso M.D., Vina J. Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis. 2009, 17:143-149.
50. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 1997, 18:457-461.
51. Lovell M.A., Markesbery W.R. Oxidatively modified RNA in mild cognitive impairment. Neurobiol. Dis. 2008, 29:169-175.
52. Ma Q.L., Yang J.F., Shao M., Dong X.M., Chen B. Association between NAD(P)H: quinone oxidoreductase and apolipoprotein E gene polymorphisms in Alzheimer's disease. Zhonghua Yi Xue Za Zhi 2003, 83:2124-2127.
53. Mangialasche F., Kivipelto M., Mecocci P., Rizzuto D., Palmer K., Winblad B., Fratiglioni L. High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age. J. Alzheimers Dis. 2010, 20:1029-1037.
54. Mariani C., Bresolin N., Farina E., Moggio M., Ferrante C., Ciafaloni E., Sertorelli S., Ciccone A., Scarlato G. Muscle biopsy in Alzheimer's disease: morphological and biochemical findings. Clin. Neuropathol. 1991, 10:171-176.
55. Matthews R.T., Yang L., Browne S., Baik M., Beal M.F. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc. Natl Acad. Sci. USA 1998, 95:8892-8897.
56. McGrath L.T., McGleenon B.M., Brennan S., McColl D., Mc I.S., Passmore A.P. Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM 2001, 94:485-490.
57. Metcalfe T., Bowen D.M., Muller D.P. Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls. Neurochem. Res. 1989, 14:1209-1212.
58. Moreira P.I., Santos M.S., Sena C., Nunes E., Seica R., Oliveira C.R. CoQ10 therapy attenuates amyloid beta-peptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp. Neurol. 2005, 196:112-119.
59. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Wilson R.S. Vitamin E and cognitive decline in older persons. Arch. Neurol. 2002, 59:1125-1132.
60. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., Wilson R.S., Aggarwal N.T., Scherr P.A. Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am. J. Clin. Nutr. 2005, 81:508-514.
61. Murphy T.H., De Long M.J., Coyle J.T. Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J. Neurochem. 1991, 56:990-995.
62. Nishida Y., Yokota T., Takahashi T., Uchihara T., Jishage K., Mizusawa H. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem. Biophys. Res. Commun. 2006, 350:530-536.
63. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:759-767.
64. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 1999, 19:1959-1964.
65. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
66. Ono K., Hasegawa K., Naiki H., Yamada M. Preformed beta-amyloid fibrils are destabilized by coenzyme Q10 in vitro. Biochem. Biophys. Res. Commun. 2005, 330:111-116.
67. Pereira C., Santos M.S., Oliveira C. Involvement of oxidative stress on the impairment of energy metabolism induced by A beta peptides on PC12 cells: protection by antioxidants. Neurobiol. Dis. 1999, 6:209-219.
68. Perkins A.J., Hendrie H.C., Callahan C.M., Gao S., Unverzagt F.W., Xu Y., Hall K.S., Hui S.L. Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am. J. Epidemiol. 1999, 150:37-44.
69. Petersen R.C., Thomas R.G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., van Dyck C.H., Thal L.J. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 2005, 352:2379-2388.
70. Polidori M.C., Mecocci P. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease. J. Alzheimers Dis. 2002, 4:517-522.
71. Pratico D., Uryu K., Leight S., Trojanoswki J.Q., Lee V.M. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 2001, 21:4183-4187.
72. Qi X.L., Xiu J., Shan K.R., Xiao Y., Gu R., Liu R.Y., Guan Z.Z. Oxidative stress induced by beta-amyloid peptide(1-42) is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells. Neurochem. Int. 2005, 46:613-621.
73. Quinn J.F., Montine K.S., Moore M., Morrow J.D., Kaye J.A., Montine T.J. Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. J. Alzheimers Dis. 2004, 6:93-97.
74. Raina A.K., Templeton D.J., Deak J.C., Perry G., Smith M.A. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox Rep. 1999, 4:23-27.
75. Rauth A.M., Goldberg Z., Misra V. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol. Res. 1997, 9:339-349.
76. Resende R., Moreira P.I., Proenca T., Deshpande A., Busciglio J., Pereira C., Oliveira C.R. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic. Biol. Med. 2008, 44:2051-2057.
77. Rosenfeldt F., Hilton D., Pepe S., Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003, 18:91-100.
78. Rosenfeldt F.L., Haas S.J., Krum H., Hadj A., Ng K., Leong J.Y., Watts G.F. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J. Hum. Hypertens. 2007, 21:297-306.
79. Ross D., Traver R.D., Siegel D., Kuehl B.L., Misra V., Rauth A.M. A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1):Relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity. Br. J. Cancer 1996, 74:995-996.
80. Rosvold E.A., McGlynn K.A., Lustbader E.D., Buetow K.H. Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking. Cancer Res. 1996, 56:5253.
81. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study. N. Engl. J. Med. 1997, 336:1216-1222.
82. Santa-Mara I., Santpere G., MacDonald M.J., Gomez de Barreda E., Hernandez F., Moreno F.J., Ferrer I., Avila J. Coenzyme q induces tau aggregation, tau filaments, and Hirano bodies. J. Neuropathol. Exp. Neurol. 2008, 67:428-434.
83. Santa-Maria I., Hernandez F., Martin C.P., Avila J., Moreno F.J. Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 2004, 43:2888-2897.
84. SantaCruz K.S., Yazlovitskaya E., Collins J., Johnson J., DeCarli C. Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease. Neurobiol. Aging 2004, 25:63-69.
85. Shan X., Lin C.L. Quantification of oxidized RNAs in Alzheimer's disease. Neurobiol. Aging 2006, 27:657-662.
86. Shan X., Tashiro H., Lin C.L. The identification and characterization of oxidized RNAs in Alzheimer's disease. J. Neurosci. 2003, 23:4913-4921.
87. Shults C.W., Haas R. Clinical trials of coenzyme Q10 in neurological disorders. Biofactors 2005, 25:117-126.
88. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Kurlan R., Molho E., Harrison M., Lew M. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 2002, 59:1541-1550.
89. Smith M.A., Zhu X., Tabaton M., Liu G., McKeel D.W., Cohen M.L., Wang X., Siedlak S.L., Dwyer B.E., Hayashi T., Nakamura M., Nunomura A., Perry G. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 2010, 19:363-372.
90. Soderberg M., Edlund C., Alafuzoff I., Kristensson K., Dallner G. Lipid composition in different regions of the brain in Alzheimer's disease/senile dementia of Alzheimer's type. J. Neurochem. 1992, 59:1646-1653.
91. Sohal R.S., Forster M.J. Coenzyme Q, oxidative stress and aging. Mitochondrion 2007, 7(Suppl):S103-S111.
92. Sultana R., Butterfield D.A. Role of oxidative stress in the progression of Alzheimer's disease. J. Alzheimers Dis. 2010, 19:341-353.
93. Sundelof J., Kilander L., Helmersson J., Larsson A., Ronnemaa E., Degerman-Gunnarsson M., Sjogren P., Basun H., Lannfelt L., Basu S. Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study. J. Alzheimers Dis. 2009, 18:71-78.
94. Sung S., Yao Y., Uryu K., Yang H., Lee V.M., Trojanowski J.Q., Pratico D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease. FASEB J. 2004, 18:323-325.
95. Tohgi H., Abe T., Nakanishi M., Hamato F., Sasaki K., Takahashi S. Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia. Neurosci. Lett. 1994, 174:73-76.
96. Traver R.D., Horikoshi T., Danenberg K.D., Stadlbauer T.H.W., Danenberg P.V., Ross D., Gibson N.W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells; characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 1992, 52:797.
97. Traver R.D., Siegel D., Beall H.D., Phillips R.M., Gibson N.W., Franklin W.A., Ross D. Characterization of a polymorphism in NADP(H):quinone oxidoreductase (DT diaphorase). Br. J. Cancer 1997, 75:69.
98. Turrens J.F., Alexandre A., Lehninger A.L. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch. Biochem. Biophys. 1985, 237:408-414.
99. Villalba J.M., Navarro F., Gomez-Diaz C., Arroyo A., Bello R.I., Navas P. Role of cytochrome b5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol. Aspects Med. 1997, 18(Suppl):S7-S13.
100. Villalba J.M., Navas P. Plasma membrane redox system in the control of stress-induced apoptosis. Antioxid. Redox Signal. 2000, 2:213-230.
101. Wadsworth T.L., Bishop J.A., Pappu A.S., Woltjer R.L., Quinn J.F. Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J. Alzheimers Dis. 2008, 14:225-234.
102. Wang B., Jin F., Xie Y., Tang Y., Kan R., Zheng C., Yang Z., Wang L. Association analysis of NAD(P)H:quinone oxidoreductase gene 609C/T polymorphism with Alzheimer's disease. Neurosci. Lett. 2006, 409:179-181.
103. Wang Y., Santa-Cruz K., DeCarli C., Johnson J.A. NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. Neurobiol. Aging 2000, 21:525-531.
104. Wiencke J.K., Spitz M.R., McMillan A., Kelsey K.T. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H:quinone oxidoreductase polymorphism. Ca Epidemiol Biol Prevent 1997, 6:87.
105. Williamson K.S., Gabbita S.P., Mou S., West M., Pye Q.N., Markesbery W.R., Cooney R.V., Grammas P., Reimann-Philipp U., Floyd R.A., Hensley K. The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 2002, 6:221-227.
106. Yang X., Dai G., Li G., Yang E.S. Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 2010, 41:110-113.
107. Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 2009, 106:14670-14675.
108. Yao Y., Chinnici C., Tang H., Trojanowski J.Q., Lee V.M., Pratico D. Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis. J. Neuroinflammation 2004, 1:21.
109. Yatin S.M., Aksenov M., Butterfield D.A. The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 1999, 24:427-435.
110. Yu B.P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 1994, 74:139-162.
111. Zaman Z., Roche S., Fielden P., Frost P.G., Niriella D.C., Cayley A.C. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease. Age Ageing 1992, 21:91-94.
112. Zhou Y., Gopalakrishnan V., Richardson J.S. Actions of neurotoxic beta-amyloid on calcium homeostasis and viability of PC12 cells are blocked by antioxidants but not by calcium channel antagonists. J Neurochem 1996, 67:1419-1425.